The Senate Appropriations Committee just released the Fiscal Year 2027 bill for HHS (and hence for NIH), along with explanatory language directed at NIH. Several metascience-related items below: Supporting Younger Researchers The case for supporting younger researchers (which here means “someone who on the verge of middle age) is strong, and this language has been in NIH appropriations since 2024.
Stuart Buck
Georgia
As seen in:
Medium,
Nature,
The MIT Press,
Scientific American,
Sensible Medicine,
Substack,
The Good Science Project,
Science Magazine,
The Dallas Morning News,
STAT
and
Executive Director, goodscienceproject.org/
Formerly: @arnold_ventures, @harvard_law, @kellogghansen
Classical guitarist and author
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Stuart Buck
Mandatory Reporting of Null Results
Note: This is a collaboration between Stuart, Aishwarya The NIH and the White House have both signaled interest in a policy requiring biomedical researchers to report null results, not just exciting positive results.
Investing In The Science Of Science: What Medicare Can Teach The NIH About Experimentation
This is a reprint of a piece I co-wrote with Kushal Kadakia and published in the journal Health Affairs in 2022. It is all the more relevant now that agencies are thinking about setting up “metascience offices.” The National Institutes of Health (NIH) today stands at a crossroads.
Science and Innovation Reception in DC
Since there are so many DC insiders who read this newsletter, what better place to advertise an upcoming launch event as to a new Bipartisan Science and Innovation Caucus? The event will be held on September 14 at the Russell Senate Office Building, and you can RSVP here. Hope to see you there! Science and innovation are fundamental to our countryʼs economic strength, security, and competitiveness. Jobs in science, technology, engineering, math, and medicine make up 34% of the U.S. workforce.
America Already Built the World's Largest Science-Vetting Machine
About this piece: Sandeep Patel and Amit Gupta are co-founders of Catalyze, to which I’m an advisor. Ian Banks is Director of Science Policy at the Foundation for American Innovation. This piece is cross-posted from Macroscience. A small part of America’s science-vetting machine: National Institutes of Health reviewers. Source. Every year, federal agencies assess over a hundred thousand proposals that they never fund.
Should We Limit the Number of Grants Per Researcher?
The NIH recently released a proposal to limit the number of grants per researcher at some level—perhaps 4, 3, or even just 2 grants. The rationale: As stewards of the taxpayers’ investments in biomedical research and in support of the NIH’s Unified Funding Strategy, the NIH must ensure that it uses funding approaches that maximize scientific productivity and innovation.
A Taxonomy of R&D Orgs
“It is a common observation, that mens studies are various, according to the different courses of life, to which they apply themselves; or the tempers of the places, wherein they live.” – Thomas Sprat, The History of the Royal-Society of London, 1667 (I.9.5) For more than a century, American philanthropists have created novel research institutions to fill the gaps left by incumbents.
Recent Metascience Articles
Lots of great reading material just in the past week: 1. On moonshots: Leya Mohsin, “The Science of Moonshots: Using Evidence to Design Transformative Initiatives” and Tom Kalil, “The Role of Philanthropy in Identifying and Pursuing AI Moonshots.” The first item here arose out of a Federation of American Scientists event called “Moonshots for Metascience, and Metascience for Moonshots” (I was a panelist).
Everything You Always Wanted to Know About Indirect Costs (But Were Afraid to Ask)
This is a guest post from Jeremy M. Berg, who is currently Professor of Computational and Systems Biology at the University of Pittsburgh. Berg received his B.S., M.S., and Ph.D. degrees in chemistry. He started as an Assistant Professor of Chemistry at Johns Hopkins University in 1986. He moved to the Johns Hopkins School of Medicine as Director of the Department of Biophysics and Biophysical Chemistry in 1990.
The Case for Pull Funding at the National Institutes of Health
This is a guest post by Sarrin Chethik, a Senior Policy Analyst at the Market Shaping Accelerator. The post was first published by the Center for Global Development and the Market Shaping Accelerator on April 16, 2026. *** The White House’s fiscal year 2027 budget proposal, released earlier this month, would cut the National Institutes of Health (NIH) funding by ~$5 billion.
US science agencies have money; can they spend it?
This is a guest post by Jordan Dworkin, an Associate Program Officer in the Abundance and Growth Fund at Coefficient Giving, where he works on innovation policy. This post was first published on the Abundance and Growth Blog. A note from Stuart: This newsletter has many readers who are members of Congress or congressional staffers.
Progress Engineering: Innovation as Social Design
Garett is Professor of Economics at George Mason University and Chief Economist at Bluechip, a stablecoin rating agency. He is author of the Singapore Trilogy published by Stanford University Press. Eliah is a Professor of Medicine and Design at UC San Diego’s Division of Infectious Diseases & Global Public Health, and the Design Lab. He directs the Center for Health Design, the CDC funded Resilient Shield, and chairs the Lancet Commission on U.S. Societal Resilience in a Global Pandemic Age.
How institutional review boards threaten groundbreaking research in higher ed
Last month, the Academic Freedom Alliance issued guidance highlighting the threat that Institutional Review Boards (IRBs) pose to the freedom to conduct research at colleges and universities. If you’re outside academia, you may not have even heard of IRBs (sometimes called Human Subjects committees). But they wield consequential power over what research is pursued in our truth-seeking institutions, and as a result the knowledge the wider public gets to have and benefit from.
Update on Metascience-Related Language in the NIH Budget
Earlier this week, the House and Senate appropriations committees released a bipartisan bill on NIH funding, along with a Joint Explanatory Statement that has a few paragraphs of metascience interest. Note as well that the House and Senate both had already released language re: NIH that is still in place unless specifically overridden by the Joint Explanatory Statement.
Proposing an NIH High-Leverage Trials (HILT) Program: Large-scale Research for Repurposing and Supplements
This is a guest article from Nicholas Reville, the Executive Director and cofounder of the Center for Addiction Science, Policy, and Research. He authored the Innovation Agenda for Addiction and speaks internationally on addiction and health policy. CASPR advances research on breakthrough therapeutics and develops novel policy interventions to reduce addiction at a population level. For more, see Nicholas’ Substack, Recursive Adaptation. A PDF version of this piece is available here.
Innovations in Scientific Institutions
At the Good Science Project, we have often written about the need for institutional diversity in science, as opposed to the current institutional isomorphism (where most organizations look and operate the same way). As I said in an interview published yesterday: When all institutions look the same, their output tends to be the same as well. Tens of thousands of scientists (usually government-funded) labor within the same constraints, incentives, and pressures to conform.
Recent Metascience News/Links
There are a number of news articles, scholarly articles, policy changes, and even a documentary film, that caught my eye recently: In Asterisk Magazine, Karthik Tadepalli makes the case that “Ideas Aren’t Getting Harder to Find.” It’s based on recent economic literature (such as this Census Bureau paper) suggesting that even though we spend far more on science and R&D than we did decades ago, the bottleneck to increased productivity and economic growth is less about the difficulty of...
Why Federal Science Agencies Should Share More Data
I originally wrote this piece a year ago, and then parts of it turned into this co-authored piece at Issues in Science and Technology. But there were several thousand words that didn’t end up being published. I thought it was worth resurrecting here. The National Institutes of Health budget was $49 billion in fiscal year 2023, while the National Science Foundation’s budget was nearly $10 billion. The overall goal is to improve scientific advancement.
Back and Forth on the Value of Replication
My friend Jordan Dworkin recently wrote an excellent piece titled, “How Much Should We Spend on Scientific Replication?” It is the first attempt to model the probability that funding replication studies will be more impactful than just funding new scientific studies. I saw the piece ahead of time, of course, but after doing a little more rumination, I have a couple of thoughts that I should have offered earlier.
Mental Health at NIH
Announcement: I have spent the past few years writing a book on NIH, and it is under contract with MIT Press. The manuscript is in the editing process right now, and there is a ~7,000-word section on mental health that we’re going to cut for the sake of word count. I’m reprinting it here, as it shows why NIH can be overly influenced by groupthink.
Venture Capital Has Lessons for Government and Philanthropy
by Aishwarya Khanduja (Analogue Group) and Stuart Buck (Good Science Project) Most basic science in the US is funded either by government or philanthropy, which collectively donate over $100 billion every year. Traditional government funding offers three things private investors usually can’t match. Democratic accountability: agencies like NIH and NSF have deployed billions of dollars guided by public interest rather than profit.
Understanding and Modeling NIH Research Grant Success Rates and the Impact of “Multiyear Funding”
This is a guest post from Jeremy M. Berg, who is currently Professor of Computational and Systems Biology at the University of Pittsburgh. Berg received his B.S., M.S., and Ph.D. degrees in chemistry. He started as an Assistant Professor of Chemistry at Johns Hopkins University in 1986. He moved to the Johns Hopkins School of Medicine as Director of the Department of Biophysics and Biophysical Chemistry in 1990.
A Reality-Based View of Government Funding of Science
This is a back-and-forth between Jeremy M. Berg (University of Pittsburgh School of Medicine, longtime NIH grant applicant, grantee, reviewer, and institute director), and Aishwarya Khanduja + me. A RESPONSE FROM DR. BERG: I read with interest “Venture Capital Has Lessons for Government and Philanthropy” by Khanduja and Buck.
We can create the future of science right now
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence.
Metascience in the House Budget . . .
The House Appropriations Committee recently adopted a bill and report that affects NIH and other agencies under the umbrella of “Labor, Health and Human Services, Education, and Related Agencies.” The bill itself doesn’t say a lot that would be relevant to metascience, with two possible exceptions.
FDA and Improved Transparency
When the FDA rejects a new drug application, it sends a so-called “complete response letter” or CRL to the company that applied for the drug approval.
The Good Science Project
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans.
Metascience in the House Budget . . .
The House Appropriations Committee recently adopted a bill and report that affects NIH and other agencies under the umbrella of “Labor, Health and Human Services, Education, and Related Agencies.” The bill itself doesn’t say a lot that would be relevant to metascience, with two possible exceptions.
The Good Science Project
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence.
The Good Science Project
When the FDA rejects a new drug application, it sends a so-called “complete response letter” or CRL to the company that applied for the drug approval.
The Good Science Project
Announcement: I have spent the past few years writing a book on NIH, and it is under contract with MIT Press. The manuscript is in the editing process right now, and there is a ~7,000-word section on mental health that we’re going to cut for the sake of word count. I’m reprinting it here, as it shows why NIH can be overly influenced by groupthink.
The Good Science Project
I originally wrote this piece a year ago, and then parts of it turned into this co-authored piece at Issues in Science and Technology. But there were several thousand words that didn’t end up being published. I thought it was worth resurrecting here. The National Institutes of Health budget was $49 billion in fiscal year 2023, while the National Science Foundation’s budget was nearly $10 billion. The overall goal is to improve scientific advancement.
The Good Science Project
Last month, the Academic Freedom Alliance issued guidance highlighting the threat that Institutional Review Boards (IRBs) pose to the freedom to conduct research at colleges and universities. If you’re outside academia, you may not have even heard of IRBs (sometimes called Human Subjects committees). But they wield consequential power over what research is pursued in our truth-seeking institutions, and as a result the knowledge the wider public gets to have and benefit from.
The Good Science Project
Garett is Professor of Economics at George Mason University and Chief Economist at Bluechip, a stablecoin rating agency. He is author of the Singapore Trilogy published by Stanford University Press. Eliah is a Professor of Medicine and Design at UC San Diego’s Division of Infectious Diseases & Global Public Health, and the Design Lab. He directs the Center for Health Design, the CDC funded Resilient Shield, and chairs the Lancet Commission on U.S. Societal Resilience in a Global Pandemic Age.
The Good Science Project
This is a guest post by Jordan Dworkin, an Associate Program Officer in the Abundance and Growth Fund at Coefficient Giving, where he works on innovation policy. This post was first published on the Abundance and Growth Blog. A note from Stuart: This newsletter has many readers who are members of Congress or congressional staffers.
The Good Science Project
This is a guest post by Sarrin Chethik, a Senior Policy Analyst at the Market Shaping Accelerator. The post was first published by the Center for Global Development and the Market Shaping Accelerator on April 16, 2026. *** The White House’s fiscal year 2027 budget proposal, released earlier this month, would cut the National Institutes of Health (NIH) funding by ~$5 billion.
This is a guest post from Jeremy M. Berg, who is currently Professor of Computational and Systems Biology at the University of Pittsburgh. Berg received his B.S., M.S., and Ph.D. degrees in chemistry. He started as an Assistant Professor of Chemistry at Johns Hopkins University in 1986. He moved to the Johns Hopkins School of Medicine as Director of the Department of Biophysics and Biophysical Chemistry in 1990.
A Reality-Based View of Government Funding of Science
This is a back-and-forth between Jeremy M. Berg (University of Pittsburgh School of Medicine, longtime NIH grant applicant, grantee, reviewer, and institute director), and Aishwarya Khanduja + me. A RESPONSE FROM DR. BERG: I read with interest “Venture Capital Has Lessons for Government and Philanthropy” by Khanduja and Buck.
Venture Capital Has Lessons for Government and Philanthropy
by Aishwarya Khanduja (Analogue Group) and Stuart Buck (Good Science Project) Most basic science in the US is funded either by government or philanthropy, which collectively donate over $100 billion every year. Traditional government funding offers three things private investors usually can’t match. Democratic accountability: agencies like NIH and NSF have deployed billions of dollars guided by public interest rather than profit.
Understanding and Modeling NIH Research Grant Success Rates and the Impact of “Multiyear Funding”
This is a guest post from Jeremy Berg, formerly the director of the National Institute of General Medical Services (NIGMS) at NIH. He has some thoughts about how often proposals succeed, and what will happen with the current move towards funding multi-year grants upfront rather than year-by-year. Understanding and Modeling NIH Research Grant Success Rates and the Impact of “Multiyear” Funding The National Institutes of Health funds the majority of the biomedical research in the United States.
Back and Forth on the Value of Replication
My friend Jordan Dworkin recently wrote an excellent piece titled, “How Much Should We Spend on Scientific Replication?” It is the first attempt to model the probability that funding replication studies will be more impactful than just funding new scientific studies. I saw the piece ahead of time, of course, but after doing a little more rumination, I have a couple of thoughts that I should have offered earlier.
Proposing an NIH High-Leverage Trials (HILT) Program: Large-scale Research for Repurposing and Supplements
This is a guest article from Nicholas Reville, the Executive Director and cofounder of the Center for Addiction Science, Policy, and Research. He authored the Innovation Agenda for Addiction and speaks internationally on addiction and health policy. CASPR advances research on breakthrough therapeutics and develops novel policy interventions to reduce addiction at a population level. For more, see CASPR.org and Nicholas’ Substack, Recursive Adaptation.
Update on Metascience-Related Language in the NIH Budget
Earlier this week, the House and Senate appropriations committees released a bipartisan bill on NIH funding, along with a Joint Explanatory Statement that has a few paragraphs of metascience interest. Note as well that the House and Senate both had already released language re: NIH that is still in place unless specifically overridden by the Joint Explanatory Statement.
The Economy of Knowing
by Aishwarya Khanduja (Analogue Group) and Stuart Buck (Good Science Project) For more than 80 years, economics has distinguished between microeconomics (how individual actors make decisions) and macroeconomics (how those decisions aggregate into large-scale patterns).1 This distinction has proven so valuable that we’ve forgotten how confusing economics was before it. This micro/macro distinction enabled different methodologies, different types of evidence, and different policy levers.
Recent Metascience News/Links
There are a number of news articles, scholarly articles, policy changes, and even a documentary film, that caught my eye recently: In Asterisk Magazine, Karthik Tadepalli makes the case that “Ideas Aren’t Getting Harder to Find.” It’s based on recent economic literature (such as this Census Bureau paper) suggesting that even though we spend far more on science and R&D than we did decades ago, the bottleneck to increased productivity and economic growth is less about the difficulty of...
Innovations in Scientific Institutions
At the Good Science Project, we have often written about the need for institutional diversity in science, as opposed to the current institutional isomorphism (where most organizations look and operate the same way). As I said in an interview published yesterday: When all institutions look the same, their output tends to be the same as well. Tens of thousands of scientists (usually government-funded) labor within the same constraints, incentives, and pressures to conform.
A Good Science Manifesto
In late 2021, I started circulating a Good Science Manifesto for possible signatures (Tyler Cowen was the first). Folks like Patrick Collison, Bruce Alberts, Marcia McNutt, and Tom Kalil provided valuable feedback; it got quite a few signatories; and it has been on the Good Science Project’s main website ever since.
A Top Scientist's Ideas as to NIH
Editor’s note: The author is a senior NIH-funded scholar at a leading U.S. research university who has served as an investigator on more than ten NIH grants and has participated in numerous NIH study sections over many years. The author requested anonymity in order to speak candidly about NIH funding structures. The Good Science Project has verified the author’s identity and funding record.
The Trump Administration recently issued an executive order titled “Unlocking Cures for Pediatric Cancer with Artificial Intelligence,” with an accompanying announcement from the Department of Health and Human Services (HHS) that they would double spending on the Childhood Cancer Data Initiative (from $50 million to $100 million). What does it actually entail?
A Compact Between Universities and Government?
Recently, the federal government released a proposed “Compact for Academic Excellence in Higher Education,” based on a proposal from investor Marc Rowan. Colleges and universities are asked to sign on, unless they “elect to forego federal benefits,” including federal research grants, tax benefits, approval of student visas, and access to student loans.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Stuart
Contact Stuart, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack